Correlation Between Neurocrine Biosciences and BARRICK

Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and BARRICK at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and BARRICK into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurocrine Biosciences and BARRICK PD AUSTRALIA, you can compare the effects of market volatilities on Neurocrine Biosciences and BARRICK and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of BARRICK. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and BARRICK.

Diversification Opportunities for Neurocrine Biosciences and BARRICK

-0.55

Correlation Coefficient

Neurocrine Biosciences  BARRICK

Excellent diversification

The 3 months correlation between Neurocrine and BARRICK is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and BARRICK PD AUSTRALIA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BARRICK PD AUSTRALIA and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with BARRICK. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BARRICK PD AUSTRALIA has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and BARRICK go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and BARRICK

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 157.88 times less return on investment than BARRICK. But when comparing it to its historical volatility, Neurocrine Biosciences is 45.83 times less risky than BARRICK. It trades about 0.02 of its potential returns per unit of risk. BARRICK PD AUSTRALIA is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  10,453  in BARRICK PD AUSTRALIA on September 23, 2024 and sell it today you would lose (63.00) from holding BARRICK PD AUSTRALIA or give up 0.6% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	80.68%
Values	Daily Returns

Neurocrine Biosciences  vs.  BARRICK PD AUSTRALIA

Neurocrine Biosciences

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

BARRICK PD AUSTRALIA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BARRICK PD AUSTRALIA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, BARRICK is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Neurocrine Biosciences and BARRICK

The main advantage of trading using opposite Neurocrine Biosciences and BARRICK positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, BARRICK can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BARRICK will offset losses from the drop in BARRICK's long position.

The idea behind Neurocrine Biosciences and BARRICK PD AUSTRALIA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.